EXPD
45
8
TROW
51
3
FITB
60
2
CAT
62
7
DE
56
10
IFF
56
3
BIIB
28
2
GM
68
3
LH
45
3
HD
55
8
VNO
50
-9
PPG
60
3
RL
68
3
TMO
47
3
CNP
63
3
AMG
52
2
RIG
58
4
UNP
45
6
WAT
53
6
ADI
47
2
EXPD
45
8
TROW
51
3
FITB
60
2
CAT
62
7
DE
56
10
IFF
56
3
BIIB
28
2
GM
68
3
LH
45
3
HD
55
8
VNO
50
-9
PPG
60
3
RL
68
3
TMO
47
3
CNP
63
3
AMG
52
2
RIG
58
4
UNP
45
6
WAT
53
6
ADI
47
2
Financhill
Back

Corvus Pharmaceuticals Vs. Perspective Therapeutics Industry Stock Comparison

Buy
58

CRVS
Corvus Pharmaceuticals

Last Price:
8.97
Seasonality Move:
-3.9%
Sell
30

CATX
Perspective Therapeutics

Last Price:
3.46
Seasonality Move:
34.33%
Buy
58
Corvus Pharmaceuticals (CRVS) is a Buy

Is Corvus Pharmaceuticals a Buy, Sell or Hold?

  • The current Corvus Pharmaceuticals [CRVS] share price is $8.94. The Score for CRVS is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • CRVS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.00. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CRVS Stock Price Chart

What is Corvus Pharmaceuticals's stock price today?

  • The Corvus Pharmaceuticals share price today is $8.94
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRVS is experiencing buying pressure, which is a positive indicator for future bullish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

CRVS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.4 Buy
Relative Strength Index (14 RSI): 60.34 Buy
Chaikin Money Flow: 638494 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.94 - 9.14) Buy
Bollinger Bands (100): (2.78 - 7.48) Buy

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.83 Sell
Relative Strength Index (14 RSI): 9.64 Sell
Chaikin Money Flow: -11653674 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.08 - 12.98) Sell
Bollinger Bands (100): (10.5 - 14.68) Sell

CRVS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.53 Buy
20-day SMA: 8.78 Buy
50-day SMA: 7.1 Buy
200-day SMA: 3.54 Buy
8-day EMA: 8.6 Buy
20-day EMA: 8.41 Buy
50-day EMA: 7.24 Buy
200-day EMA: 4.34 Buy

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.54 Sell
20-day SMA: 10.1 Sell
50-day SMA: 11.82 Sell
200-day SMA: 12.75 Sell
8-day EMA: 7.04 Sell
20-day EMA: 9.29 Sell
50-day EMA: 11.19 Sell
200-day EMA: 11.43 Sell

Corvus Pharmaceuticals Earnings Growth & CRVS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and an increase next year of $0.46 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

Corvus Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):